Dakota Wealth Management Catalyst Pharmaceuticals, Inc. Transaction History
Dakota Wealth Management
- $4.24 Billion
- Q4 2024
A detailed history of Dakota Wealth Management transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Dakota Wealth Management holds 11,320 shares of CPRX stock, worth $257,869. This represents 0.01% of its overall portfolio holdings.
Number of Shares
11,320Holding current value
$257,869% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding CPRX
# of Institutions
327Shares Held
94MCall Options Held
19.1KPut Options Held
51.1K-
Black Rock Inc. New York, NY18.7MShares$426 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.04MShares$183 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY6.23MShares$142 Million2.3% of portfolio
-
State Street Corp Boston, MA5.69MShares$130 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3.02MShares$68.8 Million0.01% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.34B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...